New Issue: Orbital Catastrophe Ahead? Read Now

U.S. Is Woefully Unprepared for Nuclear Strike

Its health system lacks the capacity to respond to attacks that use high-powered modern weapons

Operation Upshot-Knothole at the Nevada Test Site on April 18, 1953.

Join Our Community of Science Lovers!

The United States is not prepared to deal with the aftermath of a major nuclear attack, despite North Korea’s efforts to develop nuclear weapons and the increasing tensions between nations overall. That was the blunt assessment of public-health experts who participated in a meeting last week on nuclear preparedness, organized by the National Academies of Sciences, Engineering, and Medicine.

The gathering is “an acknowledgement that the threat picture has changed, and that the risk of this happening has gone up”, says Tener Veenema, who studies disaster nursing at Johns Hopkins University in Baltimore, Maryland, and co-chaired the conference in Washington DC .

Since the fall of the Soviet Union in 1991, the United States’s research and preparedness efforts for a nuclear strike have focused largely on the possibility of a terrorist attack with a relatively small, improvised 1-kilotonne weapon or a ‘dirty bomb’ that sprays radioactive material.


On supporting science journalism

If you're enjoying this article, consider supporting our award-winning journalism by subscribing. By purchasing a subscription you are helping to ensure the future of impactful stories about the discoveries and ideas shaping our world today.


But North Korea is thought to have advanced thermonuclear weapons—each more than 180 kilotonnes in size—that would cause many more casualties than would a dirty bomb (see ‘Damage estimates’). “Now that thermonuclear is back on the table, we’re back to people saying, ‘We can’t deal with this,’” says Cham Dallas, a public-health researcher at the University of Georgia in Athens.

Veenema says that the science academies decided to do a study in November 2017, three months after North Korean leader Kim Jong-un threatened to launch a nuclear weapon at the U.S. territory of Guam. The academies wanted to bring together the different government, academic and private sectors that would be involved in the medical response to a nuclear attack, Veenema adds. The academies’ committee plans to release a report in December that lays out how the United States could plug the gaps in its response capabilities.

The U.S. government’s spending on nuclear-weapons research and response has dropped drastically over the past few decades—as has the number of health workers with training in radiation medicine and management. According to a 2017 study by Dallas, more than half of emergency medical workers in the United States and Japan have no training in treating radiation victims.

The same study suggests that even trained medical professionals might be too frightened to enter a nuclear-fallout zone or to treat radiation victims at the scene—Dallas’s group found that 33% of medical professionals said they would not be willing to respond in such a scenario.

Compounding these concerns, treatments for radiation exposure and burns might not be available in sufficient quantities in the aftermath of a nuclear attack. James Jeng, a burn surgeon at Mount Sinai Health System in New York City, says that the detonation of a nuclear bomb can leave behind hundreds of thousands of burn victims. The best treatment for such injuries is skin grafting, he says, but there are only about 300 burn surgeons in the United States who know how to perform the procedure. It might also be difficult to quickly transport enough donor skin to treatment sites, Jeng adds.

North Korea’s threat to Guam last year made clear to public-health officials there how limited their response capabilities are, says Patrick Lujan, emergency-preparedness manager for the Guam Department of Public Health and Social Services. Guam, an island of 163,000 people, has only three hospitals and no burn units. “We realized there’s just so much you can do, being on an island,” Lujan says.

This article is reproduced with permission and was first published on August 28, 2018.

Sara Reardon is a freelance biomedical journalist based in Bozeman, Mont. She is a former staff reporter at Nature, New Scientist and Science and has a master’s degree in molecular biology.

More by Sara Reardon

First published in 1869, Nature is the world's leading multidisciplinary science journal. Nature publishes the finest peer-reviewed research that drives ground-breaking discovery, and is read by thought-leaders and decision-makers around the world.

More by Nature magazine

Subscribe to Support Independent Journalism

Great science journalism requires human expertise, time, effort and creativity. And it costs money. That’s why I and the journalists here at Scientific American hope you’ll join our community.

When you subscribe, you are supporting staff and freelance journalists who are passionate about telling science stories that are true, important and compelling. Our editors and reporters are often experts in their fields, which means they understand the nuances of big discoveries and can untangle the breakthroughs from the hype. With a subscription, you are also supporting rigorous fact-checking to ensure the words we publish are precise and accurate. And you’re supporting original illustrations, graphics and photos that bring you closer to an advanced laboratory, an ice sheet in Antarctica or a space mission in orbit. You’re helping us craft other types of high-quality journalism as well: Our newsletters are carefully written, edited and curated by staffers you have or will come to know and love. Our Science Quickly podcast is based on original reporting, collaboration with editors and scientists and exacting production.

Subscriptions keep this engine running so we can continue to deliver thoughtful, rigorous and independent science journalism to you. In an era of viral misinformation, this work is crucial. If you value what we do, I hope you’ll consider joining us as a subscriber

Thank you,

Jeanna Bryner, Editor in Chief, Scientific American

Subscribe